Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


 

2011 Hemispherx Biopharma Annual Meeting of Stockholders

WHERE:   Embassy Suites Hotel
                1776 Benjamin Franklin Parkway
                Philadelphia, Pennsylvania 19103

 WHEN:     Tuesday, September 18, 2012
                10:00 a.m. Eastern Time
 

Sample Proxy Cards:

2012 Hemispherx Proxy Statement

2011 Hemispherx Annual Report

2012 Hemispherx Quarterly Report for Second Quarter
Ended June 30, 2012

You will need Adobe Reader software to view the PDF files on this page.

 
 
 
 


 
 
 
 

Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.